TFCP2

transcription factor CP2

Basic information

Region (hg38): 12:51093655-51173135

Links

ENSG00000135457NCBI:7024OMIM:189889HGNC:11748Uniprot:Q12800AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the TFCP2 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the TFCP2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
11
clinvar
11
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
1
1
non coding
2
clinvar
2
Total 0 0 11 0 2

Variants in TFCP2

This is a list of pathogenic ClinVar variants found in the TFCP2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
12-51094453-A-G Benign (Jan 11, 2019)1257935
12-51095264-T-C not specified Uncertain significance (Jan 09, 2024)3176482
12-51098840-G-C not specified Uncertain significance (May 24, 2023)2551462
12-51098877-A-T not specified Uncertain significance (May 14, 2024)3325615
12-51098903-T-C not specified Uncertain significance (Dec 14, 2023)3176481
12-51098907-T-G not specified Uncertain significance (Jul 19, 2023)2599086
12-51099772-G-T not specified Uncertain significance (Jun 13, 2024)3325617
12-51101963-T-A not specified Uncertain significance (Jan 06, 2023)2474093
12-51103696-A-G not specified Uncertain significance (Aug 16, 2022)2307286
12-51104166-G-A not specified Uncertain significance (Jun 06, 2023)2557982
12-51106557-G-T not specified Uncertain significance (Apr 19, 2024)3325614
12-51107285-T-C not specified Uncertain significance (Dec 02, 2022)2332232
12-51109174-C-T not specified Uncertain significance (Jun 29, 2023)2602625
12-51110869-C-T TFCP2-related disorder Likely benign (Oct 28, 2019)3046167
12-51110977-G-A not specified Uncertain significance (Aug 08, 2022)2305849
12-51116430-T-A TFCP2-related disorder Benign (Apr 16, 2019)725865
12-51117733-T-C not specified Uncertain significance (May 24, 2024)3325616
12-51118732-T-C not specified Uncertain significance (Mar 24, 2023)2529323

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
TFCP2protein_codingprotein_codingENST00000257915 1579481
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.000003581.001257300161257460.0000636
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense2.771432720.5260.00001333333
Missense in Polyphen2272.5010.30344892
Synonymous0.2729598.40.9650.00000506917
Loss of Function3.041534.20.4390.00000186364

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00009150.0000910
Ashkenazi Jewish0.000.00
East Asian0.00005440.0000544
Finnish0.00004620.0000462
European (Non-Finnish)0.00007080.0000703
Middle Eastern0.00005440.0000544
South Asian0.0001360.000131
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Binds a variety of cellular and viral promoters including fibrinogen, alpha-globin, SV40 and HIV-1 promoters. Activation of the alpha-globin promoter in erythroid cells is via synergistic interaction with UBP1 (By similarity). Functions as part of the SSP (stage selector protein) complex. Facilitates the interaction of the gamma-globin genes with enhancer elements contained in the locus control region in fetal erythroid cells. Interacts by binding to the stage selector element (SSE) in the proximal gamma-globin promoter. {ECO:0000250, ECO:0000269|PubMed:10455131, ECO:0000269|PubMed:1732747, ECO:0000269|PubMed:8035790, ECO:0000269|PubMed:8157699}.;
Pathway
Signaling events mediated by HDAC Class I (Consensus)

Recessive Scores

pRec
0.247

Intolerance Scores

loftool
0.792
rvis_EVS
-0.45
rvis_percentile_EVS
24

Haploinsufficiency Scores

pHI
0.746
hipred
Y
hipred_score
0.715
ghis
0.684

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.801

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Tfcp2
Phenotype
normal phenotype;

Gene ontology

Biological process
regulation of transcription by RNA polymerase II;mRNA transcription by RNA polymerase II;positive regulation of transcription by RNA polymerase II
Cellular component
nucleus;nucleoplasm;cytosol;protein-containing complex
Molecular function
RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;proximal promoter sequence-specific DNA binding;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA binding;DNA-binding transcription factor activity;protein binding;transcription factor binding;sequence-specific DNA binding